The TRIH Grant aims to help strengthen the translation of fundamental research towards patient benefit. It supports:
• Research with a strong commercial potential that is likely to attract follow-on funding at the conclusion of the grant.
• Studies that will facilitate and enable the progression of promising basic research
towards testing in clinical trials.

“Identification of aminoglycoside antibiotic congeners with reduced ototoxicity: Combating aminoglycoside-induced hearing loss”.